Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

3/27/2015 Pharmaceutical Crisis

On March 26, Moscow hosted a Russian Association of Pharmaceutical Marketing (RAPM) conference, “New Threats and Opportunities of Russian Pharmaceutical Market in 2015”. Within the agenda of the conference, RNC Pharma published a forecast of the Russian pharmaceutical market after the monetary crisis of 2014-2015...

3/4/2015 Freight Heights

2/24/2015 Retail gets a panic attack

Rating of Russian pharmacy chains, following the results of 2014...

1/20/2015 Experts on the future of Russian pharmaceutical market

On the 12 of March, 2015, in St. Petersburg the branch conference“Russian pharmaceutical market through experts’ eyes. Results. Problems. Forecasts. Solutions.” will take place. It is prepared by the Pharmexperience company, by Business&Technologies Group unit. RNC Pharma is an official informational partner of the upcoming event...

12/19/2014 Crisis and a little bit of nerve

On the 4-5th of December the forum “Successful project management in pharmaceutical industry of Russia and CIS”, organized by TBM Evolution Group took place in Moscow. At the forum RNC Pharma presented current market situation overview, latest regulation initiatives and political factors evaluation, as well as its suggested consequences for the whole pharmaceutical branch...